As of 2025-07-09, the Intrinsic Value of Andlauer Healthcare Group Inc (AND.TO) is 52.32 CAD. This AND.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 53.19 CAD, the upside of Andlauer Healthcare Group Inc is -1.60%.
The range of the Intrinsic Value is 34.78 - 104.95 CAD
Based on its market price of 53.19 CAD and our intrinsic valuation, Andlauer Healthcare Group Inc (AND.TO) is overvalued by 1.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 34.78 - 104.95 | 52.32 | -1.6% |
| DCF (Growth 10y) | 46.38 - 133.04 | 68.19 | 28.2% |
| DCF (EBITDA 5y) | 29.22 - 40.38 | 34.11 | -35.9% |
| DCF (EBITDA 10y) | 40.36 - 58.25 | 48.08 | -9.6% |
| Fair Value | 44.68 - 44.68 | 44.68 | -16.00% |
| P/E | 27.83 - 50.11 | 32.83 | -38.3% |
| EV/EBITDA | 20.76 - 35.35 | 26.33 | -50.5% |
| EPV | 62.84 - 96.88 | 79.86 | 50.1% |
| DDM - Stable | 16.67 - 64.35 | 40.51 | -23.8% |
| DDM - Multi | 28.26 - 84.66 | 42.36 | -20.4% |
| Market Cap (mil) | 2,084.52 |
| Beta | 0.25 |
| Outstanding shares (mil) | 39.19 |
| Enterprise Value (mil) | 2,223.01 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.00% |
| Cost of Debt | 5.00% |
| WACC | 6.74% |